PULMATRIX, INC. Financing Cash Flow
PULMATRIX, INC. (PULM) reported Financing Cash Flow of $950.00 thousand for the 6-month period ending 2026-06-30, per its S-4/A filed 2026-09-17.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-09-17
- PULMATRIX, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$50.00K.
- PULMATRIX, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $1.00M.
- PULMATRIX, INC. net cash provided by (used in) financing activities for the quarter ending 2023-12-31 was $0.00.
- PULMATRIX, INC. net cash provided by (used in) financing activities for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- PULMATRIX, INC. net cash provided by (used in) financing activities for fiscal 2023 was $53.00K, a 95.69% decline from fiscal 2022.
- PULMATRIX, INC. net cash provided by (used in) financing activities for fiscal 2022 was $1.23M, a 97.17% decline from fiscal 2021.
- PULMATRIX, INC. net cash provided by (used in) financing activities for fiscal 2021 was $43.48M, a 107.21% increase from fiscal 2020.
- PULMATRIX, INC. net cash provided by (used in) financing activities for fiscal 2020 was $20.98M, a 18.50% increase from fiscal 2019.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$50.00K derived: S-4/A 6 month − S-4/A 3 month · filed 2026-09-17 | $950.00K S-4/A · filed 2026-09-17 | ||
| 2026-03-31 | $1.00M S-4/A · filed 2026-08-03 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | $0.00 derived: sum of 2 quarters · filed 2025-03-21 | $0.00 derived: sum of 3 quarters · filed 2025-03-21 | $53.00K 10-K · filed 2025-03-21 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $0.00 derived: sum of 2 quarters · filed 2024-11-08 | $53.00K 10-Q · filed 2024-11-08 | $53.00K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $53.00K 10-Q · filed 2024-08-13 | $53.00K derived: sum of 3 quarters · filed 2024-08-13 | $1.44M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $53.00K 10-Q · filed 2024-05-10 | $53.00K derived: sum of 2 quarters · filed 2024-05-10 | $1.44M derived: sum of 3 quarters · filed 2024-05-10 | $1.44M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $1.38M derived: sum of 2 quarters · filed 2024-03-28 | $1.38M derived: sum of 3 quarters · filed 2024-03-28 | $1.23M 10-K · filed 2024-03-28 |
| 2022-09-30 | $1.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $1.38M derived: sum of 2 quarters · filed 2023-11-09 | $1.23M 10-Q · filed 2023-11-09 | $7.42M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$152.00K 10-Q · filed 2023-08-10 | $6.04M derived: sum of 3 quarters · filed 2023-08-10 | $6.04M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$152.00K 10-Q · filed 2023-05-12 | $6.04M derived: sum of 2 quarters · filed 2023-05-12 | $6.04M derived: sum of 3 quarters · filed 2023-05-12 | $6.04M derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $6.19M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $6.19M derived: sum of 2 quarters · filed 2023-03-30 | $6.19M derived: sum of 3 quarters · filed 2023-03-30 | $43.48M 10-K · filed 2023-03-30 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 derived: sum of 2 quarters · filed 2022-11-10 | $37.28M 10-Q · filed 2022-11-10 | $37.28M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $37.28M 10-Q · filed 2022-08-10 | $37.28M derived: sum of 3 quarters · filed 2022-08-10 | $50.15M derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $37.28M 10-Q · filed 2022-05-12 | $37.28M derived: sum of 2 quarters · filed 2022-05-12 | $50.15M derived: sum of 3 quarters · filed 2022-05-12 | $58.00M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $12.87M derived: sum of 2 quarters · filed 2022-03-29 | $20.72M derived: sum of 3 quarters · filed 2022-03-29 | $20.98M 10-K · filed 2022-03-29 |
| 2020-09-30 | $12.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $20.72M derived: sum of 2 quarters · filed 2021-11-10 | $20.98M 10-Q · filed 2021-11-10 | $20.98M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $7.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $8.11M 10-Q · filed 2021-08-10 | $8.12M derived: sum of 3 quarters · filed 2021-08-10 | $8.12M derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | $260.00K 10-Q · filed 2021-05-11 | $263.00K derived: sum of 2 quarters · filed 2021-05-11 | $267.00K derived: sum of 3 quarters · filed 2021-05-11 | $14.92M derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | $7.00K derived: sum of 2 quarters · filed 2021-03-23 | $14.66M derived: sum of 3 quarters · filed 2021-03-23 | $17.70M 10-K · filed 2021-03-23 |
| 2019-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $14.65M derived: sum of 2 quarters · filed 2020-11-12 | $17.70M 10-Q · filed 2020-11-12 | $20.64M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $14.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $17.70M 10-Q · filed 2020-08-07 | $20.63M derived: sum of 3 quarters · filed 2020-08-07 | $20.62M derived: sum of 4 quarters · filed 2020-08-07 |
| 2019-03-31 | $3.05M 10-Q · filed 2020-05-14 | $5.98M derived: sum of 2 quarters · filed 2020-05-14 | $5.97M derived: sum of 3 quarters · filed 2020-05-14 | $17.71M derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | $2.93M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $2.92M derived: sum of 2 quarters · filed 2020-03-26 | $14.66M derived: sum of 3 quarters · filed 2020-03-26 | $15.79M 10-K · filed 2020-03-26 |
| 2018-09-30 | -$8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01 | $11.73M derived: sum of 2 quarters · filed 2019-11-01 | $12.86M 10-Q · filed 2019-11-01 | $13.30M derived: sum of 4 quarters · filed 2019-11-01 |
| 2018-06-30 | $11.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $12.87M 10-Q · filed 2019-08-05 | $13.31M derived: sum of 3 quarters · filed 2019-08-05 | $13.33M derived: sum of 4 quarters · filed 2019-08-05 |
| 2018-03-31 | $1.13M 10-Q · filed 2019-05-15 | $1.57M derived: sum of 2 quarters · filed 2019-05-15 | $1.59M derived: sum of 3 quarters · filed 2019-05-15 | |
| 2017-12-31 | $440.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | $463.00K derived: sum of 2 quarters · filed 2019-02-19 | $13.92M 10-K · filed 2019-02-19 | |
| 2017-09-30 | $23.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $13.48M 10-Q · filed 2018-11-14 | ||
| 2017-06-30 | $13.46M 10-Q · filed 2018-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |